Drug intelligence / Profile preview

Cryos Spray

Development stage: Unknown
Lead developer: Phyto Performance
Administration: Topical

Overview

Cryos Spray is a topical cryotherapy product manufactured by Phyto Performance, designed for the immediate treatment of minor traumatic injuries such as contusions, sprains, and swellings. Recommended by F.I.F.A. in 1987, it functions as a physical cooling agent that provides rapid relief through cryotherapy (cold therapy), helping to reduce inflammation and pain in acute sports-related injuries. It is commonly used in sports medicine as a first-response treatment and is available in a 400ml aerosol formulation.

Brand names: Cryos Spray
Other names: Phyto Performance Cryos Spray

Beyond the preview

Go deeper on Cryos Spray.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cryos Spray.

Explore the full profile